学术报告
题目：Nature-Inspired Design of Biomaterials - Pseudo Proteins and Their Biomedical Applications
报告人：Chih-Chang Chu Ph.D.
(Rebecca Q. Morgan `60 Professor of Fiber Science and Apparel Design, &Biomedical Engineering Program, Cornell University)
时间：2012 年11 月5 日（周一）下午14:00 PM
地点：北京大学现代物理研究中心102 会议室（老化学楼东配楼一层，理教路西，老光华楼北侧）
报告人简介：
Chu joined the Cornell faculty in 1978 after completing postdoctoral research on biomaterials at the Medical Center of the University of Alabama in Birmingham. He received his PhD in polymer science under the late Prof. Leo Mandelkern from the Dept. of Chemistry, Florida State University. He is the first recipient of the endowed Rebecca Q. Morgan `60 chaired professor and the recipient of the State University of New York Chancellor`s Award for Excellence in Scholarship and Creative Activities in May, 2009. He is also the guest professor of Chang-Chun Institute of Applied Chemistry, Chinese Academy of Science in Chang-Chun. Chu is also serving on the Biology/Medicine Panel of the Hong Kong Research Grant Council, and the editorial board of The Open Biomaterial Journal, The Open Material Science Journal, the J. of Bioengineering and Biomedical Sci. and J. Fiber Bioengineering and Informatics. He has published near 180 referred research papers, a recipient of 68 US and international patents and 34 pending, and an editor and author of the book “Wound Closure Biomaterials and Devices”.
Chu`s research includes the design and synthesis of new novel biodegradable polymers, and their engineering into hydrogels, microspheres, fibers and fabrics for tissue regeneration, vascular grafts, heart valves, artificial skins, bone regeneration, wound healing and infection control, wound closure, drug control/release, cancer treatment, DNA carriers for gene therapy, identification and forensic purposes. Some examples include the synthesis of new biodegradable polymers for immunotherapy of cancer patients, biomaterials for reducing restenosis of vascular stents, drug-eluting fibrous membranes for treating burn victims, novel substrates for bone, blood vessel and heart valve engineering and cell preservation, electrified sutures for wound infection control, biodegradable vascular grafts, functional wound closure biomaterials for eliminating wound infection during surgery and novel non-viral gene transfection agents. One of Dr. Chu`s new inventions `Biodegradable, Bioactive, & Programmable Hydrogels` was chosen as a semifinalist for Discover Columbus Foundation Award competition. Chu also teaches both graduate and undergraduate courses, and developed a new course “Biomaterials and Medical Devices for Human Body Repair”.
http://www.human.cornell.edu/che/bio.cfm?netid=cc62
http://www.bme.cornell.edu/bme/people/faculty/index.cfm